> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Joint Panel to Review Pfizer Osteoarthritis BLA
- URL: https://www.fdaweb.com/joint-panel-to-review-pfizer-osteoarthritis-bla/
- Published: 2021-02-16T12:00:00.000Z
- Updated: 2026-09-14T16:46:58.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5148663

*Federal Register* notice: FDA has announced a 3/24 joint meeting of the Arthritis and the Drug Safety and Risk Management Advisory Committees. Panel members are scheduled to discuss a Pfizer BLA for tanezumab subcutaneous injection, indicated for relieving signs and symptoms of moderate to severe osteoarthritis in adult patients for whom use of other analgesics is ineffective or not appropriate. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2021-02-16/pdf/2021-03068.pdf?ref=fdaweb.com).